Innate Pharma S.A. (EPA:IPH)
1.530
-0.060 (-3.77%)
Jun 23, 2025, 5:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €141.00 million as of June 23, 2025. Its market cap has decreased by -20.90% in one year.
Market Cap
141.00M
Enterprise Value
91.23M
Revenue
20.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.53
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 141.00M, an increase of 17,700.51%. That is a compound annual growth rate of 32.02%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
EssilorLuxottica Société anonyme | 111.09B |
Sanofi | 101.38B |
Sartorius Stedim Biotech | 19.58B |
bioMérieux | 14.19B |
Eurofins Scientific SE | 10.69B |
Ipsen | 8.34B |
Virbac | 2.71B |
emeis Société anonyme | 1.77B |